Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways

Cytokine

Volumn 61, Issue 2, 2013, Pages 445-454

  Pijet, Maja ^a   Pijet, Barbara ^a   Litwiniuk, Anna ^a   Pajak, Beata ^b   Gajkowska, Barbara ^b   Orzechowski, Arkadiusz ^a,b  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

C2C12 muscle cells; Insulin; Leptin; Myogenesis; SOCS3 JAK STAT3 pathway

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT LEPTIN; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HORMONE ACTION; MITOGENESIS; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOPROTECTION; FLAVONOIDS; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INTERFERON-GAMMA; JANUS KINASES; LEPTIN; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGENS; MUSCLE DEVELOPMENT; MYOBLASTS; MYOD PROTEIN; MYOGENIN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SUS SCROFA; TRANSCRIPTION, GENETIC;

EID: 84873182170     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.11.002     Document Type: Article

References (56)

1. Zhang Y., Proenca R., Maffei M., Barone M., Friedman J.M. Positional cloning of the mouse gene and its human homologue. Nature (Lond) 1994, 372:425-432.
2. Collins S., Kuhn C., Petro A.E., Swick A.G., Chrunyk B.A., Surwit R.S. Role of leptin in fat regulation. Nature (Lond) 1997, 380:677.
3. Henson M.C., Castracene V.D. Leptin in pregnancy. Biol Reprod 2000, 63:1219-1228.
4. Hoggard N., Hunter L., Duncan J.S., Williams L.M., Trayhurn P., Mercer J.G. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA 1997, 94:11073-11078.
5. Bado S., Levasseur S., Attoub S., Kermorgant J.P., Laigneau M.N., Bortoluzzi L., et al. Lewin, the stomach is a source of leptin. Nature 1998, 394:790-793.
6. Hardwick J.C., Van Debn Brink G.R., Offerhaus G.J., Van Deventer S.J., Peppelenbosch M.P. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001, 121:79-90.
7. Smith-Kirwin S.M., O'Connor D.M., De Johnson J., Lancey E.D., Hassink S.G., Funanage V.L. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 1998, 83:1810-1813.
8. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L. A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688.
9. Maroni P., Citterio L., Piccoletti R., Bendinelli P. Sam68 and ERKs regulate leptin-induced expression of OB-Rb mRNA in C2C12 myotubes. Mol Cell Endocrinol 2009, 309:26-31.
10. Maroni P., Bendinelli P., Piccoletti R. Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int 2005, 29:542-550.
11. Solberg R., Aas V., Thoresen H., Kase E.T., Drevon C.A., Rustan A.C., et al. Leptin expression in human primary skeletal muscle cells is reduced during differentiation. J Cell Biochem 2005, 96:89-96.
12. Yu T., Luo G., Zhang L., Wu J., Zhang H., Yang G. Leptin promotes proliferation and inhibits differentiation in porcine skeletal myoblasts. Biosci Biotechnol Biochem 2008, 72:13-21.
13. Hegyi K., Fulop K., Kovacs K., Toth S., Falus A. Leptin-induced signal transduction pathways. Cell Biol Int 2004, 28:159-169.
14. Ishikawa M., Kitayama J., Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004, 10:4325-4331.
15. Jin L., Burguera B.G., Couce M.E., Scheithauer W., Lamsan J., Eberhardt N.L., et al. Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role of leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999, 84:2903-2911.
16. Caldefie- Chezet F., Damez M., de Latour M., Konska G., Mishellani F., Fusilier C., et al. Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun 2005, 334:737-741.
17. White D.W., Tartalgia L.A. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev 1996, 7:303-309.
18. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but bot db/db mice. Nat Genet 1996, 14:95-97.
19. Tsuchiya T., Shimizu H., Hoie T., Mori M. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999, 365:273-279.
20. Hino M., Nakano T., Yamane T., Ohta K., Takubo T., Tatsumi N. Leptin receptor and leukemia. Leuk Lymphoma 2000, 36:457-461.
21. Tessitore L., Vizio B., Jenkin O., De Stefano I., Ritossa C., Argile J.M., et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000, 5:421-426.
22. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key?. Cancer Res 1999, 59:4493-4501.
23. Tisdale M.J. Cancer anorexia and cachexia. Nutrition 2001, 17:438-442.
24. Kotler D.P. Cachexia. Ann Intern Med 2000, 133:622-634.
25. Martignoni M.E., Kunze P., Friess H. Cancer cachexia. Mol Cancer 2003, 2:36.
26. Dhawan J., Rando T.A. Stem cells in postnatal myogenic molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 2005, 15:666-673.
27. Wagers A.J., Conboy I.M. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 2005, 122:659-667.
28. Sabourin L.A., Rudnicki M.A. The molecular regulation of myogenesis. Clin Genet 2000, 57:16-25.
29. Wu Z., Woodring P.J., Bhakta K.S., Wen K., Feramisco J.R., Karin M., et al. P38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 2000, 20:3951-3964.
30. Kwiecińska P., Roszkiewicz B., Łokociejewska M., Orzechowski A. Elevated expression of NF-κB and Bcl-2 proteins in C2C12 myocytes during myogenesis is affected by PD98059, LY294002 or SB203580 treatments. Cell Biol Int 2005, 29:319-331.
31. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1997, 270:725-727.
32. Berti L., Gammeltoft S. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol 1999, 157:121-130.
33. Maroni P., Bendinelli P., Piccoletti R. Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 2003, 201:109-121.
34. Spangenburg E.E., Booth F.W. Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol 2002, 83:C204-C211.
35. O'Shea J.J., Gadina M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the JAK/STAT pathway. Cell 2002, 83(2002):1125-1156.
36. Yang Y., Xu Y., Li W., Wang G., Song Y., Yang G., et al. STAT3 induces muscle stem cell differentiation by interaction with MyoD. Cytokine 2009, 46:137-141.
37. Sun L., Ma K., Wang H., Xiao F., Gao Y., Zhang W., et al. JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J Cell Biol 2007, 179:129-138.
38. Oberbauer A.M., Runstadler J.A., Murray J.D., Havel P.J. Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. Obes Res 2001, 9:51-58.
39. Girard I., Rezende E.L., Garland T. Leptin levels and body composition of mice selectively bred for high locomotor activity. Physiol Biochem Zool 2007, 80:568-579.
40. Shea S., Aymong E., Zybert A., Shamoon H., Tracy R.P., Deckelbaum R., et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 2003, 11:95-103.
41. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
42. Jacobson M.D., Burne J.F., Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 1994, 13:1899-1910.
43. Warmington S.A., Tolan R., McBennett S. Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse. Int J Obes 2000, 24:1040-1050.
44. Stickland N.S., Batt R.A., Crook A.R., Sutton C.M. Inability of muscles in the obese (ob/ob) to respond to changes in body weight and activity. J Anat 1994, 184:527-533.
45. Oh K.S., Kim E.Y., Yoon M., Lee C.M. Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activationg uncoupling proteins. Exp Mol Med 2007, 39:385-394.
46. Kristensen K., Pedersen S.B., Richelsen B. Interactions between sex steroid hormones and leptin in women. Studies in vivo and in vitro. Int J Obes 2000, 24:1438-1444.
47. Li L., Mamputu J.-C., Wiernsperger N., Renier G. Signaling pathways involved in human vascular muscle cell proliferation and matrix metalloproteinzse-2 expression induced by leptin. Diabetes 2005, 54:2227-2234.
48. Tanabe K., Okuya S., Tanizawa Y., Matsutani A., Oka Y. Leptin induces proliferation of β cell line MIN6 through activation of mitogen-activated protein kinase. Biochem Biophys Res Commun 1997, 241:765-768.
49. Somasundar P., Frankenberry K.A., Skinner H., Vedula G., McFadden D.W., Riggs D., et al. Prostate cancer cell proliferation is influenced by leptin. J Surg Res 2004, 18:71-82.
50. Yin N., Wang D., Zhang H., Xi Y., Sun X., Shi B., et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Canc Res 2004, 64:5870-5875.
51. Bohlen F., Kratzsch J., Mueller M., Seidel B., Friedman-Einat M., Witzigmann H., et al. Leptin inhibits cell growth of human vascular smooth muscle cells. Vasc Pharmacol 2007, 46:67-71.
52. Motta M., Accornero P., Taulli R., Bernabei P., Desrivieres S., Baratta M. Leptin enhances STAT-3 phosphorylation in HC11 cell line: effect on cell differentiation and cell viability. Mol Cell Endocrinol 2007, 263:149-155.
53. Cooney R.N. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 2002, 17:83-90.
54. Kataoka Y., Matsumura I., Ezoe S., Nakata S., Takigawa E., Sato Y., et al. Reciprocal inhibition between MyoD and STAT3 in the regulation of groth and differentiation of myoblasts. J Biol Chem 2003, 278:44178-44187.
55. Spangenburg E.E. SOCS-3 induces myoblast differentiation. J Biol Chem 2005, 280:10749-10758.
56. Diao Y., Wang X., Wu Z. SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. Mol Cell Biol 2009, 29:5084-5093.